Cybin (HELP) Intangibles (2021 - 2026)
Cybin (HELP) posted quarterly Intangibles of $30.2 million for Q1 2026, up 5.73% year-on-year from $28.6 million in Q1 2025, and down 0.71% on a QoQ basis from $30.4 million in Q4 2025.
Cybin (HELP) Intangibles (2021 - 2026) Analysis & Trends
Cybin (HELP) has reported Intangibles for 6 consecutive years, with $30.2 million the latest figure, recorded in Q1 2026.
- Quarterly Intangibles rose 5.73% year-over-year to $30.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.2 million (up 5.73% YoY) and the FY2026 annual result came in at $30.2 million, up 5.93% from the prior year.
- Intangibles fell to $30.2 million in Q1 2026 per HELP's latest filing, from $30.4 million in the prior quarter.
- Over the last five years, Intangibles for HELP reached as high as $32.5 million in Q4 2023 and fell as low as $3.9 million in Q4 2022.
- A 5-year average of $21.7 million and a median of $26.3 million in 2024 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2023 — Intangibles jumped 736.97% — and 2024, when it decreased 19.26%.
- Year by year, Intangibles stood at $3.9 million in 2022, then surged by 736.97% to $32.5 million in 2023, then retreated by 19.26% to $26.2 million in 2024, then advanced by 16.0% to $30.4 million in 2025, then decreased by 0.71% to $30.2 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $30.2 million, $30.4 million, and $30.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | 30.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.22 Mn |
| Dec 31, 2025 | 30.44 Mn |
| Sep 30, 2025 | 30.03 Mn |
| Jun 30, 2025 | 30.18 Mn |
| Mar 31, 2025 | 28.59 Mn |
| Dec 31, 2024 | 26.24 Mn |
| Sep 30, 2024 | 26.34 Mn |
| Jun 30, 2024 | 26.12 Mn |
| Mar 31, 2024 | 26.32 Mn |
| Dec 31, 2023 | 32.50 Mn |
| Sep 30, 2023 | 4.31 Mn |
| Jun 30, 2023 | 4.02 Mn |
| Dec 31, 2022 | 3.88 Mn |
| Sep 30, 2022 | 3.94 Mn |
| Dec 31, 2021 | 1.60 Mn |
| Sep 30, 2021 | 1.49 Mn |
| Jun 30, 2021 | 1.42 Mn |
| Mar 31, 2021 | 76,639.61 |